Screener / SEC EDGAR /CIK 0001874178 /10-K filed Feb 12, 2026, compared with Feb 24, 2025 /Numbers from the XBRL of the 10-Ks
Nasdaq Consumer discretionary · Automakers

Rivian Automotive, Inc. / DE RIVN

Compare with peers Embed
Planned sales, announced before they happen

1 trading plan running, 29 Form 144 notices for $10.7M

10-Q, 10-K and Form 144

What RIVN's directors and officers said they would sell, before they sold: trading plans the company reports each quarter, and the Form 144 notices sellers file on the day of a planned sale. Most of these sales are routine, such as selling shares from vesting stock awards.

Plans adopted or ended

Trading plans · XBRL, 10-Q and 10-K

From Jun 14, 2023 to Jun 12, 2027. The thin line is today; a filled bar is a plan still running, a paler one has ended or expired.

InsiderWhatDateReported in
Michael Callahan
Company’s Chief Administrative Officer and Chief Legal Officer
Adopted 10b5-1 plan Jun 12, 2026 10-Q Jul 30, 2026
What the company wrote
On June 12, 2026, Michael Callahan, the Company’s Chief Administrative Officer and Chief Legal Officer, adopted a Rule 10b5-1 trading arrangement that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act, for the sale of up to 550,000 shares of the Company’s Class A common stock. Mr. Callahan’s Rule 10b5-1 trading arrangement is scheduled to expire no later than June 12, 2027.
Robert J. Scaringe
Company’s Founder and Chief Executive Officer
Ended 10b5-1 plan Jun 1, 2026 10-Q Jul 30, 2026
What the company wrote
On June 1, 2026, Robert J. Scaringe, the Company’s Founder and Chief Executive Officer, terminated a Rule 10b5-1 trading arrangement previously adopted on March 14, 2025 and amended on June 11, 2025. On June 12, 2026, Dr. Scaringe adopted a Rule 10b5-1 trading arrangement that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act, for the sale of up to 1,142,025 shares of the Company’s Class A common stock. Dr. Scaringe’s Rule 10b5-1 trading arrangement is scheduled to expire no later than September 15, 2027.
Karen Boone
board of directors and Lead Independent Director
Adopted 10b5-1 plan Nov 24, 2025 10-K Feb 12, 2026
What the company wrote
On November 24, 2025, Karen Boone, a member of the Company’s board of directors and Lead Independent Director, adopted a Rule 10b5-1 trading arrangement that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act, for the sale of up to 20,000 shares of the Company’s Class A Common Stock. Ms. Boone’s Rule 10b5-1 trading arrangement is scheduled to expire no later than July 31, 2026.
Claire McDonough
Chief Financial Officer
Adopted 10b5-1 plan Sep 2, 2025 10-Q Nov 4, 2025
What the company wrote
On September 2, 2025, Claire McDonough, the Company’s Chief Financial Officer, adopted a Rule 10b5-1 trading arrangement that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act, for the sale of up to 237,712 shares of the Company’s Class A Common Stock. Ms. McDonough’s Rule 10b5-1 trading arrangement is scheduled to expire no later than August 25, 2026.
Robert J. Scaringe
’s Founder and Chief Executive Officer
Adopted 10b5-1 plan Mar 14, 2025 10-Q Aug 5, 2025
What the company wrote
On June 11, 2025, Robert J. Scaringe, the Company’s Founder and Chief Executive Officer, amended his Rule 10b5-1 trading arrangement that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act, which he previously adopted on March 14, 2025, as disclosed in the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2025, as filed with the SEC on May 6, 2025. As amended, the Rule 10b5-1 trading arrangement covers the sale of up to 894,195 shares of the Company’s Class A common stock and is scheduled to expire no later than September 10, 2026.
Robert J. Scaringe
Company’s Founder and Chief Executive Officer
Adopted 10b5-1 plan Mar 14, 2025 10-Q May 6, 2025
What the company wrote
On March 14, 2025, Robert J. Scaringe, the Company’s Founder and Chief Executive Officer, adopted a Rule 10b5-1 trading arrangement that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act, for the sale of up to 3,500,000 shares of the Company’s Class A common stock. Dr. Scaringe’s Rule 10b5-1 trading arrangement is scheduled to expire no later than June 12, 2026.
Claire McDonough
Chief Financial Officer
Adopted 10b5-1 plan Aug 16, 2024 10-Q Nov 7, 2024
What the company wrote
On August 16, 2024, Claire McDonough, the Company’s Chief Financial Officer, adopted a Rule 10b5-1 trading arrangement that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act, for the sale of up to 348,813 shares of the Company’s Class A common stock. Ms. McDonough’s Rule 10b5-1 trading arrangement is scheduled to expire no later than August 29, 2025.
Robert J. Scaringe
Founder and Chief Executive Officer
Adopted 10b5-1 plan Mar 8, 2024 10-Q May 7, 2024
What the company wrote
On March 8, 2024, Robert J. Scaringe, the Company’s Founder and Chief Executive Officer, adopted a Rule 10b5-1 trading arrangement that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act, for the sale of up to 4,000,000 shares of the Company’s Class A common stock. Dr. Scaringe’s Rule 10b5-1 trading arrangement is scheduled to expire no later than June 9, 2025.
Claire McDonough
Chief Financial Officer
Adopted 10b5-1 plan Jun 14, 2023 10-Q Aug 8, 2023
What the company wrote
On June 14, 2023, Claire McDonough, the Company’s Chief Financial Officer, adopted a Rule 10b5-1 trading arrangement that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act, for the sale of up to 279,936 shares of the Company’s Class A common stock. Ms. McDonough’s Rule 10b5-1 trading arrangement is scheduled to expire no later than August 20, 2024.
Show the other 1 plans

From the XBRL of the company's 10-Qs and 10-Ks (Regulation S-K Item 408, reported since 2023): 15 filings checked since May 9, 2023.

Notices of planned sales

Form 144 · Form 144 XML, SEC

What the sellers expected to sell on the Form 144 notices filed each month (the value on the notice).

FiledSellerSharesValue
Oct 1, 2026 MICHAEL J CALLAHAN
Officer
15,000 $225K
Sep 11, 2026 MICHAEL J CALLAHAN
Officer
15,000 $244K
Aug 20, 2026 CLAIRE R MCDONOUGH
Officer
8,023 $128K
Aug 18, 2026 CLAIRE R MCDONOUGH
Officer
13,144 $191K
Jul 6, 2026 RIVIAN FOUNDATION
Affiliate
166,668 $3.1M
Jul 6, 2026 KAREN BOONE
Director
20,000 $373K
Jun 3, 2026 CLAIRE R MCDONOUGH
Officer
8,022 $144K
May 29, 2026 CLAIRE R MCDONOUGH
Officer
8,023 $128K
May 28, 2026 ROBERT J. SCARINGE
Officer, Director
34,818 $522K
May 21, 2026 CLAIRE R MCDONOUGH
Officer
7,600 $106K
May 18, 2026 CLAIRE R MCDONOUGH
Officer
5,544 $74K
Apr 22, 2026 CLAIRE R MCDONOUGH
Officer
10,245 $184K
Apr 14, 2026 ROBERT J. SCARINGE
Officer, Director
21,446 $347K
Mar 31, 2026 ROBERT J. SCARINGE
Officer, Director
20,264 $304K
Mar 17, 2026 ROBERT J. SCARINGE
Officer, Director
17,450 $272K
Mar 3, 2026 ROBERT J. SCARINGE
Officer, Director
17,450 $262K
Feb 25, 2026 Rose Marcario
Director
7,183 $111K
Feb 18, 2026 ROBERT J. SCARINGE
Officer, Director
34,900 $586K
Feb 18, 2026 CLAIRE R MCDONOUGH
Officer
27,133 $456K
Jan 20, 2026 ROBERT J. SCARINGE
Officer, Director
17,450 $280K
Jan 6, 2026 RJ SCARINGE
Officer, Director
17,450 $341K
Jan 2, 2026 RIVIAN FOUNDATION
Affiliate
33,334 $657K
Dec 23, 2025 ROBERT J. SCARINGE
Officer, Director
17,450 $374K
Dec 18, 2025 Krawiec Peter
Director
3,655 $71K
Dec 15, 2025 Krawiec Peter
Director
5,572 $108K
Dec 9, 2025 RJ SCARINGE
Officer, Director
17,450 $306K
Dec 4, 2025 CLAIRE R MCDONOUGH
Officer
8,039 $145K
Dec 2, 2025 CLAIRE R MCDONOUGH
Officer
21,210 $363K
Nov 25, 2025 RJ SCARINGE
Officer, Director
17,450 $264K
Show the other 21 notices

From the Form 144 XML filed with the SEC, since Nov 25, 2025. The value is the seller's estimate on the notice. "Form 4 sales after" matches the seller's Form 4 sales in the 30 days after the notice, by name; Form 4s go back 180 days.

Sources

Regulation S-K Item 408 in the XBRL of each 10-Q and 10-K (since 2023); the Form 144 XML at the SEC.

Also

Insider trades: the Form 4s for the sales these plans led to.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/RIVN/export.csv") into a cell.

Next:Owners
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.